What is Citius Oncology, Inc.'s stock-based comp?

Citius Oncology, Inc. (CTOR) reported stock-based comp of $3.53M in Q1 2026.

How has Citius Oncology, Inc.'s stock-based comp changed year-over-year?

Citius Oncology, Inc.'s stock-based comp increased by 68.9% year-over-year, from $2.09M to $3.53M.

What is the long-term trend for Citius Oncology, Inc.'s stock-based comp?

Over 2 years (2023 to 2025), Citius Oncology, Inc.'s stock-based comp has grown at a 105.7% compound annual growth rate (CAGR), from $1.97M to $8.32M.

Citius Oncology, Inc. CTOR Stock-Based Comp

Stock-Based Comp at other companies

Iovance Biotherapeutics, Inc.IOVA

——

Gilead SciencesGILD

——

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s stock-based comp?: Citius Oncology, Inc. (CTOR) reported stock-based comp of $3.53M in Q1 2026.
How has Citius Oncology, Inc.'s stock-based comp changed year-over-year?: Citius Oncology, Inc.'s stock-based comp increased by 68.9% year-over-year, from $2.09M to $3.53M.
What is the long-term trend for Citius Oncology, Inc.'s stock-based comp?: Over 2 years (2023 to 2025), Citius Oncology, Inc.'s stock-based comp has grown at a 105.7% compound annual growth rate (CAGR), from $1.97M to $8.32M.